Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis

Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hynnekleiv, Leif, Thrane, Alexander Stanley, Krohn, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536770/
https://www.ncbi.nlm.nih.gov/pubmed/33012711
http://dx.doi.org/10.1136/bcr-2020-235194
_version_ 1783590613941223424
author Hynnekleiv, Leif
Thrane, Alexander Stanley
Krohn, Jørgen
author_facet Hynnekleiv, Leif
Thrane, Alexander Stanley
Krohn, Jørgen
author_sort Hynnekleiv, Leif
collection PubMed
description Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis and no known risk factors. To our knowledge, aqueous misdirection has not previously been associated with the use of tumour necrosis factor-alpha inhibitors.
format Online
Article
Text
id pubmed-7536770
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75367702020-10-07 Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis Hynnekleiv, Leif Thrane, Alexander Stanley Krohn, Jørgen BMJ Case Rep Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis and no known risk factors. To our knowledge, aqueous misdirection has not previously been associated with the use of tumour necrosis factor-alpha inhibitors. BMJ Publishing Group 2020-10-04 /pmc/articles/PMC7536770/ /pubmed/33012711 http://dx.doi.org/10.1136/bcr-2020-235194 Text en © BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Hynnekleiv, Leif
Thrane, Alexander Stanley
Krohn, Jørgen
Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title_full Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title_fullStr Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title_full_unstemmed Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title_short Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
title_sort simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
topic Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536770/
https://www.ncbi.nlm.nih.gov/pubmed/33012711
http://dx.doi.org/10.1136/bcr-2020-235194
work_keys_str_mv AT hynnekleivleif simultaneousbilateralaqueousmisdirectionfollowingcertolizumabtherapyforrheumatoidarthritis
AT thranealexanderstanley simultaneousbilateralaqueousmisdirectionfollowingcertolizumabtherapyforrheumatoidarthritis
AT krohnjørgen simultaneousbilateralaqueousmisdirectionfollowingcertolizumabtherapyforrheumatoidarthritis

Ejemplares similares